PharmEasy data through August 12, 2026 shows typhoid with a test-positivity rate of 25.5%, making it the most common confirmed monsoon fever among 209 Indian cities tracked. Dengue followed at 8.5%, chikungunya…
A new book, 'The Silent Syndicate: How Big Finance Is Destroying India's Healthcare' by Ameer Shahul, criticises the takeover of Indian hospitals, pharma companies, and diagnostic labs by global private equity funds…
API Holdings, the parent company of PharmEasy, has repaid Rs 1,050 crore in outstanding debt, making the digital healthcare platform debt-free. The repayment was funded through the sale of a portion of…
